GRAN INJECTION 150 [for enhancement of anti-tumor effect of dinutuximab (genetical recombination) against neuroblastoma] (グラン注射液150[神経芽腫に対するジヌツキシマブ(遺伝子組換え)の抗腫瘍効果の増強])

Pays: Japon

Langue: anglais

Source: すりの適正使用協議会 RAD-AR Council, Japan

Achète-le

Télécharger Notice patient (PIL)
01-11-2023

Ingrédients actifs:

Filgrastim(genetical recombination)

Disponible depuis:

Kyowa Kirin Co.,Ltd

DCI (Dénomination commune internationale):

Filgrastim(genetical recombination)

forme pharmaceutique:

injection

Notice patient

                                Drug Information Sheet("Kusuri-no-Shiori")
Injection
Revised: 11/2023
The information on this sheet is based on approvals granted by the
Japanese regulatory authority. Approval
details may vary by country. Medicines have adverse reactions (risks)
as well as efficacies (benefits). It is
important to minimize adverse reactions and maximize efficacy. To
obtain a better therapeutic response,
patients should understand their medication and cooperate with the
treatment.
BRAND NAME:
GRAN INJECTION 150 [FOR ENHANCEMENT OF
ANTI-TUMOR EFFECT OF DINUTUXIMAB (GENETICAL
RECOMBINATION) AGAINST NEUROBLASTOMA]
ACTIVE INGREDIENT:
Filgrastim(genetical recombination)
DOSAGE FORM:
injection
IMPRINT OR PRINT ON WRAPPING:
EFFECTS OF THIS MEDICINE
This medicine enhances the anti-tumor effect of dinutuximab (genetical
recombination). It is
usually used in combination with dinutuximab (genetical recombination)
and teceleukin
(genetical recombination) for neuroblastoma.
THE FOLLOWING PATIENTS MAY NEED TO BE CAREFUL WHEN USING THIS
MEDICINE.BE SURE TO TELL YOUR DOCTOR
AND PHARMACIST.
・If you have previously experienced any allergic reactions (itch,
rash, etc.) to any medicines
or foods.
If you have previously experienced rash or itch after administrating
any other medicines
which increase leukocytes (neutrophils).
If you have myeloid leukemia (incl. myelodysplastic syndrome) with
insufficient decrease of
leukemic cells in the bone marrow or presence of leukemic cells in the
blood.
If you are scheduled to be administered or have been administered an
anticancer agent
within 24 hours.
・If you are pregnant or breastfeeding.
・If you are taking any other medicinal products. (Some medicines may
interact to enhance or
diminish medicinal effects. Beware of over-the-counter medicines and
dietary supplements
as well as other prescription medicines.)
DOSING SCHEDULE (HOW TO TAKE THIS MEDICINE)
・
Your dosing schedule prescribed by your doctor is((         
           
to be written by a healthcare
professional
))
・In gen
                                
                                Lire le document complet
                                
                            

Rechercher des alertes liées à ce produit